SOCS2 promoted the degradation of activated FLT3, and decreased proliferation and colony formation of cells experimentally expressing FLT3-ITD40; however, these experiments were performed using the murine pro-B cell line Ba/F3, which may not be an ideal model for human AML. This evidence concerns the gene SOCS2 and acute myeloid leukemia.